Myelodysplastic syndrome: Difference between revisions

	Myelodysplastic syndrome Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Myelodysplastic syndrome from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
Echocardiography and Ultrasound
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Myelodysplastic syndrome On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Myelodysplastic syndrome All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Myelodysplastic syndrome
CDC on Myelodysplastic syndrome
Myelodysplastic syndrome in the news
Blogs on Myelodysplastic syndrome
Directions to Hospitals Treating Myelodysplastic syndrome
Risk calculators and risk factors for Myelodysplastic syndrome

Revision as of 08:08, 31 August 2012

For patient information, click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

@@ Line 40: / Line 40: @@
 ==Treatment==
-[[Myelodysplastic syndrome medical therapy|Medical Therapy]] | [[Myelodysplastic syndrome surgery|Surgery]] | [[Myelodysplastic syndrome primary prevention|Primary Prevention]] | [[Myelodysplastic syndrome secondary prevention|Secondary Prevention]] | [Myelodysplastic syndrome cost-effectiveness of therapy|Cost-Effectiveness of Therapy] | [[Myelodysplastic syndrome future or investigational therapies|Future or Investigational Therapies]] |
+[[Myelodysplastic syndrome medical therapy|Medical Therapy]] | [[Myelodysplastic syndrome surgery|Surgery]] | [[Myelodysplastic syndrome primary prevention|Primary Prevention]] | [[Myelodysplastic syndrome secondary prevention|Secondary Prevention]] | [[Myelodysplastic syndrome cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Myelodysplastic syndrome future or investigational therapies|Future or Investigational Therapies]]
 ==Related chapters==